Health Catalyst Capital (HCC) is a New York-based private equity firm specializing in high-growth healthcare information technology and tech-enabled services businesses. They focus on the U.S. healthcare market, a non-cyclical sector with an annual spend exceeding $4 trillion, where technological solutions are essential for enhancing quality of care, access, and affordability. HCC targets the lower middle market, leveraging their operational experience and industry expertise to drive significant growth and capital appreciation. Their investors include large healthcare organizations, institutional investors, family offices, healthcare entrepreneurs, and senior executives.
| Fund Size | N/A USD |
| Stages Focus | Series B, Series C, Series D, Lower middle market, Growth |
| Sectors Focus | HealthTech, Healthcare Technology, Healthcare Services, Healthcare, Healthcare Information Technology, Tech-enabled Services, Life Sciences |
| Portfolio Size | 12 companies |
Health Catalyst Capital's investment thesis is centered on identifying and supporting highly scalable healthcare businesses that leverage technology to solve complex healthcare problems, enhance patient care, and drive operational efficiencies. They target companies with innovative solutions that can significantly impact the U.S. healthcare system by improving quality of care, access, and affordability.
Active team contains 6 members (3 partners, 0 founders).
Health Catalyst Capital is a New York-based private equity firm specializing in high-growth healthcare information technology and tech-enabled services businesses.
Health Catalyst Capital is located in New York, USA.
The founding date of Health Catalyst Capital is not publicly available.
Health Catalyst Capital is a VC firm and private equity investor.
Health Catalyst Capital invests in Series B, Series C, Series D, Lower middle market, and Growth stages.
Health Catalyst Capital's check size ranges from $1,000,000 to $10,000,000 USD.
No, Health Catalyst Capital does not accept cold outreach.
The key team members at Health Catalyst Capital include Charles Boorady, Katie Carr, Tanmay Gera, John Holzwarth, Boris Pevzner, and John Sullivan.
Yes, Health Catalyst Capital invests in HealthTech.
Yes, Health Catalyst Capital invests in Healthcare Technology.